4 | $DNUT Hod14.63 ML13.94 LL10.21 the BO15 should | znewcar1 | 06/23/2023 10:21:43 AM |
3 | $DNUT hod13.62 ML12.13 RL12.73 | znewcar1 | 03/03/2023 10:36:40 AM |
2 | DNUT HOD12.66 ML10.28 | znewcar1 | 02/01/2023 3:23:49 PM |
1 | DNUT 14% v4,3M c14.91 f167M H15.29 | znewcar1 | 08/19/2021 11:18:26 PM |
Recent Articles
- North West Company Inc. Prepares for Q2 Financial Review
- AutoShop Answers Reveals Exciting 2026 Training Calendar Plans
- First American Uranium Closes Private Placement, Expanding Operations
- How Digital Realty Trust Delivered Exceptional Returns Over Time
- Acceleware Ltd. Expands Private Placement Financing Timeline
- Understanding Dow Inc.'s Legal Challenges and Stock Performance
- Understanding the Indulgence of Investing in Energy Transfer
- Zenvia Announces Fiscal Q2 2025 Earnings Release Schedule
- Alzheimer's Association Supports New Leqembi Dosing Approval
- Investors May Pursue Class Action Against Encompass Health
- Acceleware Ltd. Expands Financing Options for Growth
- Investing in Laureate Education: A 5-Year Journey to Wealth
- FDA Approves New Autoinjector for Alzheimer's Treatment
- FDA Greenlights Leqembi for Alzheimer's Maintenance Therapy
- Beijing: Blending Cultural Heritage with Modern Innovation
- Sanofi's Groundbreaking Decision for Wayrilz in the US Market
- Ocean Tides Launches Holiday Gift Wrap Multipacks on Walmart
- Understanding Knight-Swift Inc's Earnings and Market Position
- Asbestos Corporation Limited Advances Restructuring Efforts
- Rock Tech Lithium Secures $7.5 Million Investment through Offerings
- Investors Unite on Semler Scientific Securities Class Action
- Rock Tech Lithium Secures Up to $7.5 Million Fundraising
- Sword Group's 2025 Liquidity Overview with ODDO BHF
- Sanofi's Wayrilz Revolutionizes Treatment for Immune Thrombocytopenia
- Sword Group Unveils 2025 Financial Report for Investors
- Transforming $1000 Into $14,836: Ameriprise Financial's Growth
- Bravo Mining Corp. Adjusts 2024 Financial Statements After Restatement
- First Nordic Metals Reports Strong Q2 2025 Results
- Investors Prepare to Navigate Luminar Technologies Lawsuit
- Investors Stepping Forward in Spectrum Pharmaceuticals Lawsuit
- Centrus Energy Announces Participation in Key Investor Conferences
- California Energy Commission's Decision Leaves Gas Prices Unchecked
- Dr. Colleen Cowdery Strengthens Expertise at Washington Poison Center
- Immunovant Faces Investigation by Kahn Swick & Foti Law Firm
- Tamarack Resort Highlights Growth and Fire Mitigation Efforts
- Legal Inquiry into Apple Management: Key Developments Ahead
- Northland Power Reveals New Dividend Rates for Preferred Shares
- Amazing Growth: A $100 Investment in Guidewire Today
- Investors Take Action Against Semler Scientific, Inc. for Fraud
- Lundin Gold Reports Share Capital Changes and Growth Prospects
- Biomerica's Year-End Financial Review: Key Achievements and Insights
- Understanding the Semler Scientific Class Action Lawsuit Risk
- Strategic Leadership Changes at FIELDBOSS to Drive Growth
- Northland Power Unveils New Dividend Rates for Shareholders
- Anoto Group's Mid-Year Results: Key Insights and Developments
- Newcore Gold Unveils Annual Equity Incentive Awards Program
- Biomerica’s Fiscal 2025 Results: Resilient Performance Amid Challenges
- Newcore Gold's Exciting Annual Equity Incentive Award Announcement
- Understanding Shift4 Payments Inc. Financial Landscape Today
- Investing $100 in Hancock Whitney: Surprising Returns Explained